Literature DB >> 16720315

Papillomavirus genome structure, expression, and post-transcriptional regulation.

Zhi-Ming Zheng1, Carl C Baker.   

Abstract

Papillomaviruses are a group of small non-enveloped DNA tumor viruses whose infection usually causes benign epithelial lesions (warts). Certain types of HPVs, such as HPV-16, HPV-18, and HPV-31, have been recognized as causative agents of cervical cancer and anal cancer and their infections, which arise via sexual transmission, are associated with more than 95% of cervical cancer. Papillomaviruses infect keratinocytes in the basal layer of stratified squamous epithelia and replicate in the nucleus of infected keratinocytes in a differentiation-dependent manner. Viral gene expression in infected cells depends on cell differentiation and is tightly regulated at the transcriptional and post-transcriptional levels. A noteworthy feature of all papillomavirus transcripts is that they are transcribed as a bicistronic or polycistronic form containing two or more ORFs and are polyadenylated at either an early or late poly(A) site. In the past ten years, remarkable progress has been made in understanding how this complex viral gene expression is regulated at the level of transcription (such as via DNA methylation) and particularly post-transcription (including RNA splicing, polyadenylation, and translation). Current knowledge of papillomavirus mRNA structure and RNA processing has provided some clues on how to control viral oncogene expression. However, we still have little knowledge about which mRNAs are used to translate each viral protein. Continuing research on post-transcriptional regulation of papillomavirus infection will remain as a future focus to provide more insights into papillomavirus-host interactions, the virus life-cycle, and viral oncogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16720315      PMCID: PMC1472295          DOI: 10.2741/1971

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  151 in total

1.  Bovine papilloma virus-transformed cells contain multiple E2 proteins.

Authors:  N L Hubbert; J T Schiller; D R Lowy; E J Androphy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA.

Authors:  E J Androphy; D R Lowy; J T Schiller
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

3.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator.

Authors:  P F Lambert; B A Spalholz; P M Howley
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

4.  Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens.

Authors:  F Thierry; J M Heard; K Dartmann; M Yaniv
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms.

Authors:  D Smotkin; H Prokoph; F O Wettstein
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs.

Authors:  J Choe; P Vaillancourt; A Stenlund; M Botchan
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells.

Authors:  C C Baker; J S Noe
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Oltersdorf; E Schwarz; L Gissmann
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

9.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer.

Authors:  P Hawley-Nelson; E J Androphy; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  161 in total

1.  The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2.

Authors:  Noor Gammoh; Daniela Gardiol; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

2.  Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches.

Authors:  Danielle Bottalico; Zigui Chen; Boštjan J Kocjan; Katja Seme; Mario Poljak; Robert D Burk
Journal:  J Gen Virol       Date:  2012-05-02       Impact factor: 3.891

Review 3.  Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

4.  High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods.

Authors:  Heather M Walline; Chris Komarck; Jonathan B McHugh; Serena A Byrd; Matthew E Spector; Samantha J Hauff; Martin P Graham; Emily Bellile; Jeffrey S Moyer; Mark E Prince; Gregory T Wolf; Douglas B Chepeha; Francis P Worden; Matthew H Stenmark; Avraham Eisbruch; Carol R Bradford; Thomas E Carey
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-12       Impact factor: 6.223

5.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

7.  Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.

Authors:  Janet L Brandsma; Ying Sun; Paul M Lizardi; David P Tuck; Daniel Zelterman; G Kenneth Haines; Maritza Martel; Malini Harigopal; Kevin Schofield; Matthew Neapolitano
Journal:  Virology       Date:  2009-05-13       Impact factor: 3.616

Review 8.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

9.  Autogenous translational regulation of the Borna disease virus negative control factor X from polycistronic mRNA using host RNA helicases.

Authors:  Yohei Watanabe; Naohiro Ohtaki; Yohei Hayashi; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

10.  Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland.

Authors:  John F Menton; Suzanne M Cremin; Lydie Canier; Mary Horgan; Liam J Fanning
Journal:  Virol J       Date:  2009-07-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.